Terug
Dagbereik
€ 26,84
€ 28,45
52-Weeksbereik
€ 4,81
€ 44,89
Volume
368.182
50D / 200D Gem.
€ 35,10
/
€ 22,42
Vorige Slotkoers
€ 28,14
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,8 | 0,3 |
| P/B | 2,5 | 2,9 |
| ROE % | -27,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 55,33
+98.9%
Low: € 18,00
High: € 88,00
Forward WPA
-€ 2,85
Omzet Sch.
0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 1,61
-€ 1,61 – -€ 1,61
|
260 M | 5 |
| FY2029 |
-€ 3,09
-€ 3,09 – -€ 3,09
|
130 M | 2 |
| FY2028 |
-€ 4,44
-€ 5,85 – -€ 1,87
|
27 M | 7 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -81,88M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-27,76%
ROIC-19,89%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio24,62
Interest Coverage0,00
Waardering
P/E Ratio
-10,75
P/B Ratio2,53
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -86,97M |
| ROE | -27,76% | ROA | -22,58% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -81,88M |
| ROIC | -19,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 24,62 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,75 | P/B Ratio | 2,53 |
| P/S Ratio | N/A | PEG Ratio | -0,46 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 934,56M | Enterprise Value | 859,87M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -86,97M | -61,92M | -32,56M | -26,14M |
| EPS (Diluted) | -2,38 | -1,85 | -1,02 | -0,82 |
| Gross Profit | -248.000,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -98,06M | -68,19M | -35,31M | -25,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 385,14M | 268,54M | 84,18M | 45,10M |
| Total Liabilities | 15,92M | 11,09M | 156,65M | 87,70M |
| Shareholders' Equity | 369,22M | 257,44M | -72,47M | -42,61M |
| Total Debt | 596.000,0 | 171.000,0 | 324.000,0 | 461.000,0 |
| Cash & Equivalents | 75,29M | 49,35M | 30,52M | 24,21M |
| Current Assets | 381,54M | 267,29M | 83,47M | 44,21M |
| Current Liabilities | 15,50M | 11,05M | 3,93M | 3,43M |